Deslanoside Injection
» Deslanoside Injection is a sterile solution of Deslanoside in a suitable solvent. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C47H74O19. It may contain Glycerin.
Packaging and storage— Preserve in single-dose containers, preferably of Type I glass.
USP Reference standards 11—
USP Deslanoside RS Click to View Structure
Identification— Transfer a volume of Injection, equivalent to about 2 mg of deslanoside, to a small separator, and extract with 25 mL of a mixture of 7 volumes of chloroform and 3 volumes of alcohol. Transfer the extract to a 10-mL conical flask, evaporate on a steam bath to dryness, and dissolve the residue in 500 µL of methanol. Proceed with a 5-µL portion of the solution so obtained, as directed in the Identification test under Deslanoside, beginning with “Apply 5 µL of this solution.” The specified result is obtained.
pH 791: between 5.5 and 7.0.
Other requirements— It meets the requirements under Injections 1.
Assay—
Standard preparation— Prepare as directed in the Assay under Deslanoside.
Assay preparation— Transfer a volume of Injection, equivalent to about 600 µg of deslanoside, to a separator, and add 50 mL of water and 1 mL of 2 N sulfuric acid. Extract with four 30-mL portions of a mixture of 5 volumes of chloroform and 1 volume of n-propyl alcohol, washing each portion in a second separator containing 5 mL of water and filtering through cotton that previously has been moistened with chloroform. Combine the extracts, and evaporate on a steam bath, with the aid of a current of air, just to dryness. Transfer the residue, with the aid of a small volume of the chloroform–n-propyl alcohol mixture, to a 25-mL conical flask.
Procedure— Transfer 3.0 mL each of the Standard preparation and of alcohol to provide the blank to separate 25-mL conical flasks. Using these solutions and the Assay preparation, proceed as directed for Procedure in the Assay under Deslanoside, beginning with “Evaporate each with gentle warming.” Calculate the quantity, in µg, of C47H74O19 in each mL of the Injection taken by the formula:
(C / V)(AU / AS)
in which C is the concentration, in µg per mL, of USP Deslanoside RS in the Standard preparation; V is the volume, in mL, of Injection taken; and AU and AS are the maximum absorbances of the solutions from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Sujatha Ramakrishna, Ph.D.
Senior Scientific Liaison
1-301-816-8349		 (SM22010) Monographs - Small Molecules 2
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 2826